for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Oragenics Acquires Noachis Terra Inc

May 4 (Reuters) - Oragenics Inc:

* ORAGENICS ACQUIRES NOACHIS TERRA INC., TO DEVELOP ITS TERRACOV2 NIH-GENERATED SARS-COV-2 (COVID 19) VACCINE CANDIDATE UTILIZING “SPIKE PROTEIN”

* ORAGENICS INC - AS A RESULT OF DEAL, PAID $1.9 MILLION IN CASH

* ORAGENICS - AS A RESULT OF DEAL, ISSUED 9.2 MILLION CO’S SHARES & WARRANTS TO BUY 9.2 MILLION OF CO’S SHARES, CARRYING EXERCISE PRICE OF $1.25/SHARE & 5-YEAR TERM

* ORAGENICS INC - PLANS TO FINANCE CLINICAL TRIALS FOR TERRACOV2 WITH ITS AVAILABLE CASH AND ANY GRANT FUNDS THAT MAY BE AWARDED BY BARDA OR NIH Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up